Search
Descriptor English: Ancitabine
Descriptor Spanish: Ancitabina
Descriptor ancitabina
Entry term(s) anhidro-ARA-C
ciclocitidina
Scope note: Congénere de la CITARABINA que se metaboliza a citarabina y, de esta manera, mantiene una acción antineoplásica más constante.
Descriptor Portuguese: Ancitabina
Descriptor French: Ancitabine
Entry term(s): Cyclocytidine
NSC-145,668
NSC-145668
NSC145668
U-33,624A
U-33624A
U33624A
Tree number(s): D03.383.742.680.245.453.050
D13.570.065.300.050
D13.570.685.245.453.050
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D003504
Scope note: Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Antimetabolites, Antineoplastic
Registry Number: DO2D32W0VC
CAS Type 1 Name: 6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R-(2alpha,3beta,3abeta,9abeta))-
DeCS ID: 3524
Unique ID: D003504
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1976/04/13
Revision Date: 2016/05/27
Ancitabine - Preferred
Concept UI M0005461
Preferred term Ancitabine
Entry term(s) Cyclocytidine
NSC-145,668 - Narrower
Concept UI M0376273
Preferred term NSC-145,668
Entry term(s) NSC-145668
NSC145668
U-33,624A - Narrower
Concept UI M0372336
Preferred term U-33,624A
Entry term(s) U-33624A
U33624A



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey